hotspot -WSS

hotspot

author：leisure time 2025-09-27 21:27:41 - browse：33884

Paul Biondi Flagship

Pharma giant Pfizer is turning to venture firm Flagship for new drug development, signing a deal worth up to $7 billion to mine new medicines from the latter’s portfolio companies.

Flagship and Pfizer announced Tuesday that they will each put $50 million into developing up to 10 drug candidates. Pfizer will have first rights to acquire each for up to $700 million, plus royalties. Flagship’s portfolio companies will also share in any payments that come out of the partnership.

Flagship has historically developed new medicines by forming and spinning out startup companies, some of which have signed their own collaboration deals with the likes of Amgen or Nestlé Health Science. But in recent years, the firm has been pursuing external partnerships through a new business division called Pioneering Medicines, led by former Bristol Myers Squibb executive Paul Biondi. Pioneering Medicines uses technologies and other scientific platforms being developed by Flagship’s portfolio companies to look for possible therapies in disease areas that the startup may not be working in.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Rep. Raul Ruiz on the physician shortage and more

hotspot

focus

WSS

FDA investigates CAR

Study gives hint on South Asians’ higher risk of cardiovascular disease

Despite FDA concern, risk that CAR

Fetal surgery at risk from Dobbs and new abortion restrictions

Juul documents reveal insider tactics on political lobbying

30 years of 'Listening to Prozac'

focus

hotspot

hotspot

Alkermes shareholders re

Pediatric cancer treatments threatened by a new FDA policy

Alkermes shareholders re

BIO selects John Crowley as new CEO

23andMe had bad news about my health. I wish a person had delivered it

Will the market for weight loss drugs really reach $100 billion?

Hollywood unions extend contract negotiations for actors

Organ aging and disease risk measured by new blood test

Medicare proposal to cover medical devices draws a mixed reaction

Will the market for weight loss drugs really reach $100 billion?

entertainment

Why don't Americans have at

Bernie Sanders gets little from pharma CEOs on drug prices

Congress considering partial increase for doctor pay in Medicare

Why don't Americans have at

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

How to pay for weight loss drugs and save Medicare

hotspot

knowledge

focus

entertainment